Literature DB >> 23737700

Response to Bernardi and colleagues.

Mustapha Tehfe1.   

Abstract

Year:  2013        PMID： 23737700      PMCID： PMC3671037          DOI： 10.3747/co.20.1374

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  3 in total

1.  Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution.

Authors:  K Damiens; J P M Ayoub; B Lemieux; F Aubin; W Saliba; M P Campeau; M Tehfe
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

2.  Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer.

Authors:  I H Park; J Ro; K S Lee; B H Nam; Y Kwon; K H Shin
Journal:  Ann Oncol       Date:  2008-07-29       Impact factor: 32.976

3.  Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras.

Authors:  Irene Karam; Sarah Hamilton; Alan Nichol; Ryan Woods; Caroline Speers; Hagen Kennecke; Scott Tyldesley
Journal:  Radiat Oncol       Date:  2013-01-09       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.